{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:02:22Z","timestamp":1760144542308,"version":"build-2065373602"},"reference-count":23,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>We are writing in response to comments made by Shah and Ramasamy [...]<\/jats:p>","DOI":"10.3390\/pathogens13050353","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T05:26:13Z","timestamp":1714022773000},"page":"353","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reply to Shah, J.S.; Ramasamy, R. Target Antigens in Western and Line Immunoblots for Supporting the Diagnosis of Lyme Disease. Comment on \u201cPorwancher et al. Immunoblot Criteria for Diagnosis of Lyme Disease: A Comparison of CDC Criteria to Alternative Interpretive Approaches. Pathogens 2023, 12, 1282\u201d"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4152-4383","authenticated-orcid":false,"given":"Richard","family":"Porwancher","sequence":"first","affiliation":[{"name":"Section of Allergy, Immunology, and Infectious Diseases, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA"},{"name":"Princeton Infectious Diseases Associates, LLC, Plainsboro, NJ 08536, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Levin","sequence":"additional","affiliation":[{"name":"Kephera Diagnostics, LLC, Framingham, MA 01702, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalie","family":"Trevejo","sequence":"additional","affiliation":[{"name":"Acute and Communicable Disease Prevention, Oregon Health Authority, Portland, OR 97232, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Shah, J., and Ramasamy, R. (2024). Target Antigens in Western and Line Immunoblots for Supporting the Diagnosis of Lyme Disease. Comment on Porwancher et al. Immunoblot Criteria for Diagnosis of Lyme Disease: A Comparison of CDC Criteria to Alternative Interpretive Approaches. Pathogens 2023, 12, 1282. Pathogens, 13.","DOI":"10.3390\/pathogens12111282"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Porwancher, R., Levin, A., and Trevejo, R. (2023). Immunoblot Criteria for Diagnosis of Lyme Disease: A Comparison of CDC Criteria to Alternative Interpretive Approaches. Pathogens, 12.","DOI":"10.3390\/pathogens12111282"},{"key":"ref_3","first-page":"56","article-title":"Improved clinical sensitivity for detection of antibodies to Borrelia burgdorferi by Western blots prepared from a mixture of two strains of B. burgdorferi, 297 and B31, and interpreted by in-house criteria","volume":"4","author":"Shah","year":"2010","journal-title":"Eur. Infect. Dis."},{"key":"ref_4","first-page":"7","article-title":"Improved Sensitivity of Lyme disease Western blots Prepared with a Mixture of Borrelia burgdorferi strains 297 and B31","volume":"1","author":"Shah","year":"2014","journal-title":"Chronic Dis. Int."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Liu, S., Du Cruz, I., Ramos, C.C., Taleon, P., Ramasamy, R., and Shah, J. (2018). Pilot Study of Immunoblots with Recombinant Borrelia burgdorferi Antigens for Laboratory Diagnosis of Lyme Disease. Healthcare, 6.","DOI":"10.3390\/healthcare6030099"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1086\/516173","article-title":"The western immunoblot for Lyme disease: Determination of sensitivity, specificity, and interpretive criteria with use of commercially available performance panels","volume":"25","author":"Tilton","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"ref_7","unstructured":"(2024, January 07). Available online: https:\/\/igenex.com\/igenex-immunoblot-test\/."},{"key":"ref_8","unstructured":"(2023, April 14). Available online: https:\/\/igenex.com\/disease\/borrelia."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1128\/JCM.00874-16","article-title":"Lyme Borreliosis Serology: Performance of Several Commonly Used Laboratory Diagnostic Tests and a Large Resource Panel of Well-Characterized Patient Samples","volume":"54","author":"Molins","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.idc.2022.03.004","article-title":"Epidemiology of Lyme Disease","volume":"36","author":"Mead","year":"2022","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3201\/eid2901.220930","article-title":"Genomic Confirmation of Borrelia garinii, United States","volume":"29","author":"Rudenko","year":"2023","journal-title":"Emerg. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1473-3099(15)00464-8","article-title":"Identification of a novel pathogenic Borrelia species causing Lyme borreliosis with unusually high spirochaetaemia: A descriptive study","volume":"16","author":"Pritt","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1086\/314663","article-title":"Evaluation of two-test serodiagnostic method for early Lyme disease in clinical practice","volume":"179","author":"Trevejo","year":"1999","journal-title":"J. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1128\/jcm.34.6.1353-1354.1996","article-title":"Recommendation to include OspA and OspB in the new immunoblotting criteria for serodiagnosis of Lyme disease","volume":"34","author":"Hilton","year":"1996","journal-title":"J. Clin. Microbiol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Arnaboldi, P.M., Katseff, A.S., Sambir, M., and Dattwyler, R.J. (2022). Linear Peptide Epitopes Derived from ErpP, p35, and FlaB in the Serodiagnosis of Lyme Disease. Pathogens, 11.","DOI":"10.3390\/pathogens11080944"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Wojciechowska-Koszko, I., Kwiatkowski, P., Sienkiewicz, M., Kowalczyk, M., Kowalczyk, E., and Dolegowska, B. (2022). Cross-Reactive Results in Serological Tests for Borreliosis in Patients with Active Viral Infections. Pathogens, 11.","DOI":"10.3390\/pathogens11020203"},{"key":"ref_17","unstructured":"CDC (1995). Recommendations for test performance and interpretation from the second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb. Mortal. Wkly. Rep., 44, 590\u2013591."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"703","DOI":"10.15585\/mmwr.mm6832a4","article-title":"Updated CDC Recommendation for Serologic Diagnosis of Lyme Disease","volume":"68","author":"Mead","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1128\/JCM.01409-14","article-title":"Collection and characterization of samples for establishment of a serum repository for lyme disease diagnostic test development and evaluation","volume":"52","author":"Molins","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3904\/kjim.2016.195","article-title":"An overview of meta-analysis for clinicians","volume":"33","author":"Lee","year":"2018","journal-title":"Korean J. Intern. Med."},{"key":"ref_21","unstructured":"(2024, January 08). Meta-Analysis, Available online: www.pubmed.gov."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Sfeir, M.M., Meece, J.K., Theel, E.S., Granger, D., Fritsche, T.R., Steere, A.C., and Branda, J.A. (2022). Multicenter Clinical Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Using Zeus Scientific Commercial Assays. J. Clin. Microbiol., 60.","DOI":"10.1128\/jcm.02528-21"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1128\/JCM.43.8.3602-3609.2005","article-title":"Improvement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulin G (IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues","volume":"43","author":"Goettner","year":"2005","journal-title":"J. Clin. Microbiol."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/13\/5\/353\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:33:46Z","timestamp":1760106826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/13\/5\/353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,25]]},"references-count":23,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["pathogens13050353"],"URL":"https:\/\/doi.org\/10.3390\/pathogens13050353","relation":{},"ISSN":["2076-0817"],"issn-type":[{"type":"electronic","value":"2076-0817"}],"subject":[],"published":{"date-parts":[[2024,4,25]]}}}